Phase to Phase - The Guide to Drug Development
Experts will present on innovative strategies in outsourcing discovery. In this session, experts will focus on innovative strategies to discovery that allows small companies to focus on their core discovery needs and frees them up from both a capital and manpower investment.
In this session, attendees will hear from experts about outsourcing discovery research – Evaluating your options!
- Challenges for early-stage biotech companies surrounding their discovery efforts.
- Innovative strategies to help focus your Discovery efforts without putting significant pressure on your organization.
- Benefits of incorporating innovative outsourcing strategies throughout your discovery programs.
- How best to choose an outsourcing strategy that maximizes benefit for your company.
- Erik Willems, PhD., Senior Manager Cell Biology, Research and Development, Thermo Fisher Scientific
- Moderator: Tim Peters-Strickland, MD, Vice President, Global Medical Officer, Biotech Solutions, PPD, part of Thermo Fisher Scientific
Erik Willems, PhD.
Erik Willems was trained as a stem cell biologist in Brussels, Belgium where he obtained his PhD in 2007. As a postdoc he then developed expertise in the use of pluripotent stem cells in high throughput screening assays for understanding the basic biology and disease of the developing heart at the Sanford Burnham Prebys Medical Discovery Institute in San Diego, California.
Pursuing his passion for the development and application of biotechnology tools, Erik currently leads a team focused on customer driven projects at Thermo Fisher Scientific in Carlsbad, California. Ongoing services projects involve the generation of cell models (cell engineering, reprogramming and stem cell differentiation) and tool production (genome editing and virus tools) as well as their implementation in drug discovery applications (assay development and screening) and cell therapy.
Refund/cancellation policy: This program is offered free of charge. As such refunds are not applicable. Questions: Contact Lauren Boyle, [email protected]